US Patent Issued to ASKA PHARMACEUTICAL on Feb. 10 for "Methods for differentiating destructive thyroiditis from other pathological conditions" (Japanese Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,546,788, issued on Feb. 10, was assigned to ASKA PHARMACEUTICAL Co. LTD. (Tokyo).

"Methods for differentiating destructive thyroiditis from other pathological conditions" was invented by Yuji Tanaka (Tokyo), Yosuke Ono (Tokyo) and Naoya Fujita (Tokyo).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described is a method for differentiating destructive thyroiditis, including measuring at least one of monoiodotyrosine and diiodotyrosine in a sample."

The patent was filed on March 31, 2021, under Application No. 17/995,181.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect...